Amid a documented shortage of behavioral and mental health service providers in large urban areas, the use of VR simulations ...

The research showed that semaglutide drugs, known as GLP-1 agonists, slow the speed at which alcohol enters the bloodstream.

A celebrated Vancouver researcher used fabricated data and hid evidence of infected wounds to falsely claim his patented skin ...

There's mounting evidence that popular drugs prescribed for diabetes management and weight loss—better known by trade names ...

Doing targeted COPD case finding as part of NHS lung cancer checks could save £33m over the next decade, research has shown.

A damning new report revealed that domestic abuse is ‘everyday business’ for the Family Courts, yet a pro-contact culture and ...

They trap sediments, absorb excess nutrients and turn pollutants into less harmful substances. Now, the list of pollutants ...

Australia’s first psychedelic trial for treatment-resistant depression has uncovered potential markers that could predict ...

Among underserved and minority children with high-risk asthma, remote therapeutic monitoring was deemed feasible and met with ...

Trump administration program, launching Jan. 1, will affect patients and their doctors in Texas and five other states.

A New York Times health reporter explains what makes a good study, and how she knows which papers merit an article.

Professor Dai Chunyan from Chongqing Technology and Business University and Professor Michael Pollitt from the University of Cambridge have jointly published a study exploring the coordination ...